Skip to main content
. 2021 Jun 9;12(3):564–572. doi: 10.1055/s-0041-1731287

Table 3. Baseline characteristics of patients in the adherence and nonadherence groups.

Adherence Nonadherence p -Value
n 234 805
Male (%) 34 40 0.15
Age (y) 75.4 ± 6.8 75.7 ± 7.0 0.46
Current smoker (%) 4.3 4.0 0.83
Hypertension (%) 87 86 0.78
Diabetes (%) 24 21 0.46
Hyperlipidemia (%) 41 40 0.90
Systolic blood pressure (mmHg) 132.3 ± 12.1 131.9 ± 15.3 0.88
Diastolic blood pressure (mmHg) 74.4 ± 9.0 74.3 ± 10.3 0.44
Pulse (bpm) 74.7 ± 12.1 73.8 ± 13.8 0.47
Body weight (kg) 56.9 ± 10.0 58.1 ± 11.2 0.13
Laboratory data
White blood cell (1,000/mm 3 ) 5.8 ± 1.4 5.8 ± 1.8 0.54
Hemoglobin (g/dL) 13.2 ± 1.4 13.2 ± 1.5 0.57
Total protein (g/dL) 7.1 ± 0.4 7.2 ± 0.5 0.29
Aspartate aminotransferase (IU/L) 24.2 ± 8.6 25.5 ± 10.3 0.67
Alanine transaminase (IU/L) 22.6 ± 14.0 22.4 ± 13.7 0.74
Creatinine (mg/dL) 0.7 ± 0.2 0.7 ± 0.2 0.20
Blood urea nitrogen (mg/dL) 15.9 ± 3.8 16.7 ± 4.8 0.19
Low-density lipoprotein (mg/dL) 111.7 ± 28.7 107.7 ± 26.1 0.04
High-density lipoprotein (mg/dL) 60.6 ± 17.4 60.4 ± 17.7 0.96
Triglycerides (mg/dL) 123.7 ± 69.5 123.6 ± 81.1 0.67
Total cholesterol (mg/dL) 184.7 ± 31.6 183.0 ± 37.1 0.43
Hemoglobin A1c 5.9 ± 0.6 6.0 ± 0.7 0.40
Na (mEq/L) 142.7 ± 2.5 142.3 ± 2.7 0.04
K (mEq/L) 4.4 ± 0.4 4.4 ± 0.5 0.52
B-type natriuretic peptide (pg/mL) 84.1 ± 122.1 71.8 ± 101.0 0.55
Medications
Angiotensin-converting enzyme inhibitor (%) 7.2 11.3 0.07
Angiotensin-receptor blocker (%) 48.3 50.1 0.61
Beta-blocker (%) 4.7 5.5 0.65
Calcium blocker (%) 66.7 65.7 0.79
Aldosterone antagonist (%) 1.7 2.9 0.33
Statin (%) 40.1 39.6 0.88
Acetylsalicylic acid (%) 4.3 9.4 0.01
Warfarin (%) 3.0 1.9 0.29
Direct oral anticoagulant (%) 3.0 2.4 0.59
Loop diuretic (%) 3.0 3.2 0.86

Note: Patients of general practitioners not following specialist's recommendations and all control group patients were included in the nonadherence group. Continuous variables are expressed as the mean ± standard deviation.